NewAmsterdam Pharma (NAMS) Return on Assets [ROA] (2024 - 2026)
NewAmsterdam Pharma's Return on Assets [ROA] came in at -36.12% for Q2 2026, down 15.83 percentage points from -20.29% a year earlier and down 7.79 percentage points from the prior quarter.
Powered by 
Analysis
NewAmsterdam Pharma (NAMS) Return on Assets [ROA] (2024 - 2026) Analysis & Trends
For FY2025, NewAmsterdam Pharma's Return on Assets [ROA] was -24.95%, up 14.93 percentage points from FY2024.
- Return on Assets [ROA] carries a three-year change of +5.17 percentage points (FY2022 to FY2025).
- Going back by year, Return on Assets [ROA] was -39.88% in FY2024 (+2.99 pp), -42.86% in FY2023 (-12.74 pp) and -30.12% in FY2022.
- The Q2 2026 figure represents the lowest quarterly Return on Assets [ROA] since Q4 2024.
- Year-over-year, Return on Assets [ROA] increased in four of the last six quarters, with an average year-over-year change of +11.25 percentage points.
- Business Quant data shows NAMS's Return on Assets [ROA] at -28.33% (Q1 2026), -26.20% (Q4 2025) and -27.61% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.00% |
| 10 | NewAmsterdam Pharma | 2.30 Bn | -236.30 Mn | - | -29.43% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -29.43% |
| Jun 30, 2026 | -36.12% |
| Mar 31, 2026 | -28.33% |
| Dec 31, 2025 | -26.20% |
| Sep 30, 2025 | -27.61% |
| Jun 30, 2025 | -20.29% |
| Mar 31, 2025 | -22.26% |
| Dec 31, 2024 | -37.06% |
| Sep 30, 2024 | -44.91% |
| Jun 30, 2024 | -49.06% |
| Mar 31, 2024 | -54.74% |
API Access
NewAmsterdam Pharma Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=NAMS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "NAMS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=NAMS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();